Sundowning is a common condition, or syndrome, among people with dementia, and is associated with some adverse outcomes, such as institutionalization, faster cognitive worsening, and greater caregiver burden, according to a study published in Frontiers in Medicine online Dec. 27, 2016. It is characterized by the worsening or emergence of
Tag: cholinesterase inhibitors
Alzheimer’s disease treatment is, in many respects, still a question in search of a definitive answer. No Alzheimer medication can halt the forward progress of the disease or prevent its ultimate devastation on the lives of those who have it.
Yet Alzheimer dementia medications are available that can help relieve some
The critical difference between Alzheimer’s and dementia is that Alzheimer’s is a specific disease and dementia is a term used to describe symptoms that can be caused by a number of different diseases, including Alzheimer’s disease (AD). So, the answer to the question, “Is there a difference between Alzheimer’s and
It is well documented in scientific literature that aging is associated with certain cognitive changes. As we get older, we experience some gradual decline in conceptual reasoning, memory, and processing speed, but these changes don’t keep us from going about our normal activities.
Dementia, on the other hand, can significantly affect
Reseachers are hard at work trying to figure out what causes dementia. In the case of Alzheimer’s disease (AD), they are trying to learn the process associated with an Alzheimer’s cause. They are learning that there’s a multifactorial process associated with AD, triggered by a combination of environmental and genetic
At this time, Alzheimer’s disease treatment is more about managing symptoms than about stopping or reversing the disease course. Existing therapies can’t cure Alzheimer’s, but they can help relieve some of its most troubling symptoms, and make life easier for both those with the condition, and their caregivers. New treatments
Alzheimer’s disease (AD) is turning into a true epidemic. Today, more than 5 million Americans live with the effects of this disease, according to the Alzheimer’s Association, and the numbers are climbing. By 2050, nearly 14 million people over age 65 will have developed Alzheimer’s. The cost of caring for
Despite reports of promising new therapies for Alzheimer’s disease, there is still no cure. One or more of the drugs currently being tested may offer hope, but the results of those studies are still a few years away. In the meantime, there are drugs that can treat some of the
What is vascular dementia? It refers to a spectrum of cognitive impairments resulting from damage to blood vessels in the brain. Stroke, either a significant singular stroke or multiple smaller strokes, is a major cause of vascular dementia (VaD), but any disease process that damages blood vessels in the brain
Apathy—feelings of indifference and lack of interest and motivation—is an important harbinger of dementia In people who go on to develop Alzheimer’s disease (AD) and other dementias, emotional and behavioral changes that reflect this growing loss of interest may be the first signal of cognitive problems.
“Apathy is a strong clinical